This story has been updated from a version posted Dec. 16 to include additional information from company officials.

By Justin Petrone

Rheonix last week introduced its Hy-Fi microarray platform for biomarker discovery and clinical diagnostics.

John Brenner, the firm's vice president of IP management and licensing, told BioArray News that the Hy-Fi array platform enables multiplexed end-point detection for molecular assays, especially SNP detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.